The latest quarterly EBITDA is $1.66 Million. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) measures a company's operating performance by removing non-cash charges and capital structure effects.
Q2 FY2026 (2026-06-30).
Reported quarterly EBITDA; no daily interpolation. Q2 FY2026 (2026-06-30): $1.66M.
EBITDA growth vs the same fiscal quarter in the prior fiscal year, last 9 comparable quarters.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A Quote observation: 2026-10-06T19:22:41.917Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
$1.66M
$1.66 Million
Q2 FY2026 · 2026-06-30
N/A
16
Quarters of data available
| Period | EBITDA | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $1.66M | N/A | +793.42% |
| Q1 FY2026Period end 2026-03-31 | −$988.88K | N/A | +62.86% |
| Q4 FY2025Period end 2025-12-31 | $2.81M | +52.70% | N/A |
| Q3 FY2025Period end 2025-09-30 | $1.84M | +887.86% | +432.44% |
| Q2 FY2025Period end 2025-06-30 | $185.96K | N/A | -94.84% |
| Q1 FY2025Period end 2025-03-31 | −$2.66M | -170.18% | N/A |
| Q4 FY2024Period end 2024-12-31 | −$985.44K | N/A | N/A |
| Q3 FY2024Period end 2024-09-30 | $345.02K | -90.43% | -93.47% |
| Q2 FY2024Period end 2024-06-30 | $3.61M | -10.29% | +55.01% |
| Q1 FY2024Period end 2024-03-31 | $4.02M | -15.89% | +452.70% |
| Q4 FY2023Period end 2023-12-31 | $4.78M | -9.62% | +797.74% |
| Q3 FY2023Period end 2023-09-30 | $5.29M | +127.28% | +822.79% |
| Q2 FY2023Period end 2023-06-30 | $2.33M | +219.87% | N/A |
| Q1 FY2023Period end 2023-03-31 | $727.09K | +36.62% | N/A |
| Q4 FY2022Period end 2022-12-31 | $532.18K | -7.10% | N/A |
| Q3 FY2022Period end 2022-09-30 | $572.84K | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.